Filing Details
- Accession Number:
- 0001818382-24-000067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-21 16:08:57
- Reporting Period:
- 2024-05-20
- Accepted Time:
- 2024-05-21 16:08:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1818382 | Humacyte Inc. | HUMA | Biological Products, (No Disgnostic Substances) (2836) | 851763759 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1877453 | N. Max Wallace | 2525 East North Carolina Highway 54 Durham NC 27713 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-05-20 | 4,015 | $6.21 | 4,015 | No | 4 | P | Indirect | Max Wallace SEP IRA |
Common Stock | Acquisiton | 2024-05-20 | 3,990 | $6.29 | 3,990 | No | 4 | P | Indirect | Max N Wallace IRA |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Max Wallace SEP IRA |
No | 4 | P | Indirect | Max N Wallace IRA |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 56,550 | Direct |